Afficher la notice abrégée

dc.contributor.authorLoricera J, J
dc.contributor.authorCastañeda, S
dc.contributor.authorMoriano, C
dc.contributor.authorNarváez, J
dc.contributor.authorAldasoro, V
dc.contributor.authorMaiz, O
dc.contributor.authorMelero, R
dc.contributor.authorVilla, I
dc.contributor.authorVela, P
dc.contributor.authorRomero-Yuste, S
dc.contributor.authorCallejas Rubio, José Luis 
dc.date.accessioned2025-01-28T11:16:37Z
dc.date.available2025-01-28T11:16:37Z
dc.date.issued2022-07
dc.identifier.citationLoricera J, Castañeda S, Moriano C, Narváez J, Aldasoro V, Maiz O, Melero R, Villa I, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sánchez-Martín J, Sánchez-Bilbao L, Calderón-Goercke M, Casado A, Hernández JL, González-Gay MA, Blanco R. Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients. Ther Adv Musculoskelet Dis. 2022 Jul 22;14:1759720X221113747. doi: 10.1177/1759720X221113747. (IF: 5.35; Q1)es_ES
dc.identifier.urihttps://hdl.handle.net/10481/100732
dc.language.isoenges_ES
dc.publisherTher Adv Musculoskelet Dises_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleTocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patientses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1177/1759720X221113747


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional